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INTRODUCTION
Pemphigus vulgaris (PV) is a rare autoimmune blistering 
disease involving the skin and mucosa. In PV, mucosal lesions 
usually develop in the oral and pharyngeal areas.1 The involve-
ment of the esophagus is rare;2,3 however, some authors suggest 
that it may be more prevalent than expected. When involve-
ment of the esophagus is present in PV, the most common pre-
senting symptoms are dysphagia and odynophagia. In one 
prior study of esophageal PV, dysphagia, and odynophagia 
was present in 57.1% and 21.4% of the patients, respectively, 
whereas hematemesis was present in only 3.5%.4 Here, we pres-
ent two cases with PV with initial symptoms of hematemesis. 
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CASE REPORTS
Case 1
A 41-year-old female patient presented to our hospital emer-
gency center with the chief complaint of hematemesis that de-
veloped 2 hours ago (total amount, >1 L). PV had been patho-
logically confirmed in this patient 5 years ago through skin 
biopsy. Her skin lesions had recurrently aggravated with the 
discontinuation of corticosteroids, and thus she had been on 
maintenance therapy for >3 years (oral methylprednisolone 10 
mg daily and mycophenolate mofetil [MMF] 500 mg twice dai-
ly). She had no other medical history.
On physical examination, her initial blood pressure was 90/60 
mm Hg, pulse rate was 97 beats per minute, respiratory rate 
was 20 breaths per minute, and body temperature was 37.5°C. 
She showed multiple scars on the face and upper chest due to 
the healing of earlier skin involvement of PV; however, she 
did not show any active bullae or desquamation. The base-
line laboratory results were as follows: hemoglobin level, 10.7 
g/dL; white blood cell count, 19,010/μL; and platelet count, 
479,000/μL. The serum levels of routine chemistry markers 
were within the reference limits.
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Initial esophagogastroduodenoscopy showed severe mu-
cosal edema and erythema on the oropharynx and laryngeal 
area, with desquamation (Fig. 1A). From the upper esopha-
geal sphincter to the lower esophagus, there was diffuse exfo-
liation of the mucosa with multiple linear ulcerations and ero-
sions (Fig. 1B). There was no current active bleeding; however, 
subepithelial hemorrhage was present, with the friable mu-
cosa bleeding easily on touching (Fig. 1C). The gastric mu-
cosa and duodenal mucosa were well preserved without signs 
of hemorrhage or mucosal breakage. Because of the concern 
of additional bleeding risk, esophageal biopsy was not done. 
Immediately after the endoscopy was done, the patient expe-
rienced dyspnea and her oxygen saturation dropped to 88% 
on pulse oximetry monitoring, owing to severe laryngeal ede-
ma. She shortly recovered completely in a few minutes after 
supplementation with oxygen and administration of 100 mg 
intravenous hydrocortisone. Thereafter, she was maintained 
on intravenous hydrocortisone 100 mg twice daily for 6 days, 
and did not show any signs or symptoms of gastrointestinal 
bleeding or airway obstruction. After diet build-up and switch-
ing to oral methylprednisolone 16 mg daily with MMF 500 mg 
twice daily, she was discharged on the 11th day of hospitaliza-
tion. We recommended a follow-up evaluation of esophago-
gastroduodenoscopy for pathologic confirmation of the diag-
nosis; however, the patient refused. She is currently in remission 
status on MMF 500 mg twice daily and methylprednisolone 
8 mg daily, without recurrent hematemesis.
Case 2 
A 30-year-old female patient was referred to our hospital 
emergency center with hematemesis that started several hours 
before her presentation. The hematemesis had a total amount 
of 500 mL, had the color of fresh blood, and was combined 
with sloughed tissue material. PV had been diagnosed in this 
patient 11 months previously. Two weeks previously, her der-
matologist had decided to increase the quantity of her medi-
cation because of new formation of vesicles on her skin. After 
switching from oral methylprednisolone 2 mg daily, cyclospo-
rine 50 mg twice daily, and MMF 1,000 mg twice daily to oral 
methylprednisolone 4 mg daily, cyclosporine 150 mg twice 
daily, and MMF 1,000 mg twice daily, the skin lesions had 
shown improvement at the time of admission.
On physical examination, her initial blood pressure was 
140/90 mm Hg, pulse rate was 118 beats per minute, respirato-
ry rate was 20 breaths per minute, and body temperature was 
36.5°C. She did not show any newly or recently developed skin 
lesions but had chronic scars due to PV on the trunk, ingui-
nal, and perioral skin areas. The baseline laboratory results 
were as follows: hemoglobin level, 10.0 g/dL; white blood cell 
count, 16,940/μL; and platelet count, 262,000/μL. The serum 
Fig. 1. Endoscopic findings. (A) Diffuse swelling of the larynx with oral desquamation. (B) Multiple erosions and shallow ulcers with exfoliation of 
the esophageal mucosal tissue. (C) Diffuse subepithelial hemorrhage of the esophagus.
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Fig. 2. Endoscopic findings. (A) Mucosal abrasions on the oral cavity wall. (B) Erythematous mucosa with severe edema of the larynx. (C) Linear 
ulceration in the esophagus covered with exudate.
A  B C
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levels of routine chemistry markers were within the reference 
limits.
Initial esophagogastroduodenoscopy results revealed mul-
tiple mucosal abrasions in the oral cavity (Fig. 2A), with com-
bined laryngeal edema (Fig. 2B). In the upper esophagus, 
there was a longitudinal ulceration covered with exudate, and 
diffuse mucosal friability and erythema that was consistent 
with the findings of exfoliative esophagitis (Fig. 2C). There 
was no abnormality in the lower esophagus, stomach, and du-
odenum. After the administration of intravenous hydrocorti-
sone 100 mg twice daily for 2 days, the patient did not show 
any other symptoms, and we were able to rapidly taper off 
the corticosteroids. On the third day of hospitalization, she 
underwent a follow-up esophagogastroduodenoscopy, which 
showed markedly improved mucosal exfoliative lesions in 
the oral cavity (Fig. 3A) and upper esophagus (Fig. 3B), for 
which biopsy was done. The final pathology report indicated 
detached squamous epithelium, with acute and chronic inflam-
mation and necroinflammatory exudates. She was discharged 
on the sixth day of hospitalization with MMF 1,000 mg twice 
daily. Thereafter, she was referred back to a local clinic, and has 
not returned to our center.
DISCUSSION
Esophageal involvement of autoimmune blistering skin dis-
eases is a rare condition that, even when present, may be under-
recognized or misdiagnosed without a proper endoscopic eval-
uation.5,6
In our two cases, esophageal involvement of PV presented 
with a large amount of upper gastrointestinal bleeding. Both 
patients showed severe laryngeal edema, which can lead to 
desaturation and dyspnea, as in case 1. On endoscopic evalu-
ation in both cases, mucosal lesions were found in the oro-
pharynx, with exfoliative esophagitis.
We successfully treated both patients with early adminis-
tration of systemic corticosteroids and immunosuppressive 
therapy after confirming the diagnosis of esophageal involve-
ment of PV. As most patients with PV are frequently main-
tained on oral corticosteroid therapy, which is a risk factor for 
peptic ulcer disease that may lead to ulcer bleeding, the pos-
sibility of peptic ulcer should be ruled out before additional 
corticosteroid administration. The recognition of esophageal 
involvement is important, as early management with cortico-
steroids and immunosuppressive therapy may improve the 
clinical outcome. Thus, in patients with PV or other autoim-
mune blistering skin diseases, early endoscopic evaluation may 
be indicated when signs or symptoms of esophageal involve-
ment are present.7
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Fig. 3. Endoscopic findings. (A) Improvement of laryngeal edema and oral mucosal lesions. (B) Resolved status of mucosal lesions in the esoph-
agus.
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